A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

NCT07307274 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Overweight and Obese Adults

Interventions

DRUG: SYNT101
DRUG: Placebo

Sponsor

Syntis Bio